Global Neglected Tropical Diseases Diagnosis Market Overview:
Global Neglected Tropical Diseases Diagnosis Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2024-2035, Considering the Base Year As 2025.
Global Neglected Tropical Diseases Diagnosis Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2035, with base year as 2025. This research study of Neglected Tropical Diseases Diagnosis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Neglected Tropical Diseases Diagnosis Market:
The Neglected Tropical Diseases Diagnosis Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Neglected Tropical Diseases Diagnosis Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Neglected Tropical Diseases Diagnosis Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Neglected Tropical Diseases Diagnosis market has been segmented into:
Serological Testing
Molecular Diagnostics
Microscopy
Immunological Assays
By Application, Neglected Tropical Diseases Diagnosis market has been segmented into:
Lymphatic Filariasis
Schistosomiasis
Leprosy
Chagas Disease
Dengue
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neglected Tropical Diseases Diagnosis market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neglected Tropical Diseases Diagnosis market.
Top Key Players Covered in Neglected Tropical Diseases Diagnosis market are:
Siemens Healthineers
Merck
Becton Dickinson
Hologic
BioRad Laboratories
Qiagen
Cepheid
Thermo Fisher Scientific
Abbott
Agilent Technologies
Johnson and Johnson
Roche
Novartis
Deloitte
GlaxoSmithKline
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Neglected Tropical Diseases Diagnosis Market Type
4.1 Neglected Tropical Diseases Diagnosis Market Snapshot and Growth Engine
4.2 Neglected Tropical Diseases Diagnosis Market Overview
4.3 Serological Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.3.3 Serological Testing: Geographic Segmentation Analysis
4.4 Molecular Diagnostics
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.4.3 Molecular Diagnostics: Geographic Segmentation Analysis
4.5 Microscopy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.5.3 Microscopy: Geographic Segmentation Analysis
4.6 Immunological Assays
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.6.3 Immunological Assays: Geographic Segmentation Analysis
Chapter 5: Neglected Tropical Diseases Diagnosis Market Application
5.1 Neglected Tropical Diseases Diagnosis Market Snapshot and Growth Engine
5.2 Neglected Tropical Diseases Diagnosis Market Overview
5.3 Lymphatic Filariasis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.3.3 Lymphatic Filariasis: Geographic Segmentation Analysis
5.4 Schistosomiasis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.4.3 Schistosomiasis: Geographic Segmentation Analysis
5.5 Leprosy
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.5.3 Leprosy: Geographic Segmentation Analysis
5.6 Chagas Disease
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.6.3 Chagas Disease: Geographic Segmentation Analysis
5.7 Dengue
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.7.3 Dengue: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Neglected Tropical Diseases Diagnosis Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 SIEMENS HEALTHINEERS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 MERCK
6.4 BECTON DICKINSON
6.5 HOLOGIC
6.6 BIORAD LABORATORIES
6.7 QIAGEN
6.8 CEPHEID
6.9 THERMO FISHER SCIENTIFIC
6.10 ABBOTT
6.11 AGILENT TECHNOLOGIES
6.12 JOHNSON AND JOHNSON
6.13 ROCHE
6.14 NOVARTIS
6.15 DELOITTE
6.16 GLAXOSMITHKLINE
Chapter 7: Global Neglected Tropical Diseases Diagnosis Market By Region
7.1 Overview
7.2. North America Neglected Tropical Diseases Diagnosis Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Serological Testing
7.2.2.2 Molecular Diagnostics
7.2.2.3 Microscopy
7.2.2.4 Immunological Assays
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Lymphatic Filariasis
7.2.3.2 Schistosomiasis
7.2.3.3 Leprosy
7.2.3.4 Chagas Disease
7.2.3.5 Dengue
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Neglected Tropical Diseases Diagnosis Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Serological Testing
7.3.2.2 Molecular Diagnostics
7.3.2.3 Microscopy
7.3.2.4 Immunological Assays
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Lymphatic Filariasis
7.3.3.2 Schistosomiasis
7.3.3.3 Leprosy
7.3.3.4 Chagas Disease
7.3.3.5 Dengue
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Neglected Tropical Diseases Diagnosis Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Serological Testing
7.4.2.2 Molecular Diagnostics
7.4.2.3 Microscopy
7.4.2.4 Immunological Assays
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Lymphatic Filariasis
7.4.3.2 Schistosomiasis
7.4.3.3 Leprosy
7.4.3.4 Chagas Disease
7.4.3.5 Dengue
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Neglected Tropical Diseases Diagnosis Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Serological Testing
7.5.2.2 Molecular Diagnostics
7.5.2.3 Microscopy
7.5.2.4 Immunological Assays
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Lymphatic Filariasis
7.5.3.2 Schistosomiasis
7.5.3.3 Leprosy
7.5.3.4 Chagas Disease
7.5.3.5 Dengue
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Neglected Tropical Diseases Diagnosis Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Serological Testing
7.6.2.2 Molecular Diagnostics
7.6.2.3 Microscopy
7.6.2.4 Immunological Assays
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Lymphatic Filariasis
7.6.3.2 Schistosomiasis
7.6.3.3 Leprosy
7.6.3.4 Chagas Disease
7.6.3.5 Dengue
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Neglected Tropical Diseases Diagnosis Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Serological Testing
7.7.2.2 Molecular Diagnostics
7.7.2.3 Microscopy
7.7.2.4 Immunological Assays
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Lymphatic Filariasis
7.7.3.2 Schistosomiasis
7.7.3.3 Leprosy
7.7.3.4 Chagas Disease
7.7.3.5 Dengue
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Neglected Tropical Diseases Diagnosis Scope:
|
Report Data
|
Neglected Tropical Diseases Diagnosis Market
|
|
Neglected Tropical Diseases Diagnosis Market Size in 2025
|
USD XX million
|
|
Neglected Tropical Diseases Diagnosis CAGR 2025 - 2032
|
XX%
|
|
Neglected Tropical Diseases Diagnosis Base Year
|
2024
|
|
Neglected Tropical Diseases Diagnosis Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Siemens Healthineers, Merck, Becton Dickinson, Hologic, BioRad Laboratories, Qiagen, Cepheid, Thermo Fisher Scientific, Abbott, Agilent Technologies, Johnson and Johnson, Roche, Novartis, Deloitte, GlaxoSmithKline.
|
|
Key Segments
|
By Type
Serological Testing
Molecular Diagnostics
Microscopy
Immunological Assays
By Applications
Lymphatic Filariasis
Schistosomiasis
Leprosy
Chagas Disease
Dengue
|
